Medline Inc. logo
Medline Inc. (MDLN)
Compare

Medline Inc. (MDLN) Return on Equity (ROE): 8.55%

Is Medline Inc.’s return on equity (ROE) high or low?

Medline Inc.'s return on equity (ROE) of 8.55% is 76% above its 5-year average of 4.86%, near the high end of its 5-year range (0.00%–10.79%).

The return on equity (ROE) for Medline Inc. (MDLN) is 8.55% as of Thursday, June 11, 2026. It is below its 12-month average by 5.26% (9.02%).

MDLN Return on Equity (ROE) Chart

MDLN Return on Equity (ROE)
10.79%+48.62% 1Y
Zoom

MDLN Average Return on Equity (ROE) Chart

MDLN Current vs Average Return on Equity (ROE) Chart

MDLN Return on Equity (ROE) Metrics

RETURN ON EQUITY (ROE)

8.55%

RETURN ON EQUITY (ROE) AVG TTM

9.02%

RETURN ON EQUITY (ROE) AVG 3Y

4.86%

RETURN ON EQUITY (ROE) AVG 5Y

4.86%

RETURN ON EQUITY (ROE) AVG 10Y

4.86%

RETURN ON EQUITY (ROE) AVG 15Y

4.86%

RETURN ON EQUITY (ROE) AVG 20Y

4.86%

CURRENT VS TTM AVG

-5.26%

CURRENT VS 3Y AVG

+76.02%

CURRENT VS 5Y AVG

+76.02%

CURRENT VS 10Y AVG

+76.02%

CURRENT VS 15Y AVG

+76.02%

CURRENT VS 20Y AVG

+76.02%

MDLN Competitors' Return on Equity (ROE)

NAMEMARKET CAPRETURN ON EQUITY (ROE)TTM3Y5Y
Medline Inc. (MDLN)$30.90B8.55%9.02%4.86%4.86%
IQVIA Holdings Inc. (IQV)$30.08B22.26%21.77%21.17%17.55%
Centene Corporation (CNC)$32.26B-30.07%-10.46%-1.37%1.10%
Biogen Inc. (BIIB)$28.94B7.36%8.42%11.86%16.52%
DexCom, Inc. (DXCM)$28.92B31.47%28.93%25.01%22.95%
Zoetis Inc. (ZTS)$34.27B81.75%66.19%56.82%52.60%
Veeva Systems Inc. (VEEV)$26.73B12.89%12.42%12.32%13.45%
Agilent Technologies, Inc. (A)$37.17B19.85%20.59%21.51%20.54%
Waters Corporation (WAT)$23.60B2.94%29.98%64.02%111.55%
Mettler-Toledo International Inc. (MTD)$22.82B-3677.41%-2178.82%-341.14%-117.12%

Return Analysis

ROE

8.6%

ROA

2.5%

Medline Inc. Return on Equity (ROE) Formula & Definition

ROE = Net Income / Total Shareholders' Equity

Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Medline Inc. Return on Equity (ROE) FAQ

What is the return on equity (ROE) for Medline Inc. (MDLN)?
The return on equity (ROE) for MDLN stock is 8.55%.
Is Medline Inc.'s return on equity (ROE) high or low?
Medline Inc.'s return on equity (ROE) of 8.55% is 76% above its 5-year average of 4.86%, near the high end of its 5-year range (0.00%–10.79%).
What is the TTM average return on equity (ROE) for Medline Inc. (MDLN)?
The TTM average return on equity (ROE) for MDLN stock is 9.02%.
What is the 3Y average return on equity (ROE) for Medline Inc. (MDLN)?
The 3Y average return on equity (ROE) for MDLN stock is 4.86%.
What is the 5Y average return on equity (ROE) for Medline Inc. (MDLN)?
The 5Y average return on equity (ROE) for MDLN stock is 4.86%.
What is the 10Y average return on equity (ROE) for Medline Inc. (MDLN)?
The 10Y average return on equity (ROE) for MDLN stock is 4.86%.
What is the 15Y average return on equity (ROE) for Medline Inc. (MDLN)?
The 15Y average return on equity (ROE) for MDLN stock is 4.86%.
What is the 20Y average return on equity (ROE) for Medline Inc. (MDLN)?
The 20Y average return on equity (ROE) for MDLN stock is 4.86%.

Medline Inc. Return on Equity (ROE) History

DATERETURN ON EQUITY (ROE)
2025-12-3110.79%
2024-12-317.26%
2023-12-311.38%
2022-12-310.00%

About Medline Inc.

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

Northfield, IL
43,000 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
James Boyle